{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:38:18Z","timestamp":1787931498368,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["H-2404-110-1532"],"award-info":[{"award-number":["H-2404-110-1532"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["CAREMM-2305"],"award-info":[{"award-number":["CAREMM-2305"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003655","name":"National Institute of Food and Drug Safety Evaluation","doi-asserted-by":"publisher","award":["RS-2023-00216446"],"award-info":[{"award-number":["RS-2023-00216446"]}],"id":[{"id":"10.13039\/501100003655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jtct.2024.11.010","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T18:38:15Z","timestamp":1732646295000},"page":"74.e1-74.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Bispecific T-Cell Engagers in Relapsed\/Refractory Multiple Myeloma: A Real-World Data-Based Case-Controlled Study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5438-7819","authenticated-orcid":false,"given":"Suein","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Min","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8826-4136","authenticated-orcid":false,"given":"Sung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1766-1425","authenticated-orcid":false,"given":"Seungpil","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-5120","authenticated-orcid":false,"given":"Seunghoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6162-5571","authenticated-orcid":false,"given":"Jung Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Woo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3044-3991","authenticated-orcid":false,"given":"Seung-Ah","family":"Yahng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-7459","authenticated-orcid":false,"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2024.11.010_bib0001","first-page":"2420","article-title":"Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible","volume":"109","author":"Engelhardt","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2024.11.010_bib0002","first-page":"4137","article-title":"Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)","volume":"113","author":"Knop","year":"2009","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.jtct.2024.11.010_bib0003","first-page":"10","article-title":"Multiple myeloma","volume":"1046","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2024.11.010_bib0004","doi-asserted-by":"crossref","first-page":"m3176","DOI":"10.1136\/bmj.m3176","article-title":"Emerging immunotherapies in multiple myeloma","volume":"370","author":"Shah","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.jtct.2024.11.010_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41420-024-01818-6","article-title":"Targeted immunotherapy: harnessing the immune system to battle multiple myeloma","volume":"10","author":"Xu","year":"2024","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.jtct.2024.11.010_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41571-020-0427-6","article-title":"CAR T cell therapies for patients with multiple myeloma","volume":"18","author":"Mikkilineni","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2024.11.010_bib0007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/cer-2017-0046","article-title":"PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies","volume":"7","author":"Garside","year":"2018","journal-title":"Journal of Comparative Effectiveness Research"},{"key":"10.1016\/j.jtct.2024.11.010_bib0008","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/cpt.2882","article-title":"Development of an external control arm using electronic health record-based real-world data to evaluate the efficacy of COVID-19 treatment","volume":"113","author":"Jeon","year":"2023","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.jtct.2024.11.010_bib0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s41669-018-0110-3","article-title":"The role of real-world evidence in UK reimbursement: case study of lenalidomide in myelodysplastic syndrome deletion 5q","volume":"3","author":"Lee","year":"2019","journal-title":"PharmacoEconomics-Open"},{"key":"10.1016\/j.jtct.2024.11.010_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.920336","article-title":"Licensing of orphan medicinal products\u2014use of real-world data and other external data on efficacy aspects in marketing authorization applications concluded at the European medicines agency between 2019 and 2021","volume":"13","author":"Naumann-Winter","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.jtct.2024.11.010_bib0011","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1182\/blood-2021-153503","article-title":"FDA Oncology Center of Excellence Review of Real World Data Submissions Supporting Drug Development in Hematologic Malignancies","volume":"138","author":"Rivera","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.11.010_bib0012","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-024-03111-2","article-title":"A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases","volume":"19","author":"Vaghela","year":"2024","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/j.jtct.2024.11.010_bib0013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate behavioral research"},{"key":"10.1016\/j.jtct.2024.11.010_bib0014","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/cpt.857","article-title":"When and how can real world data analyses substitute for randomized controlled trials?","volume":"102","author":"Franklin","year":"2017","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.jtct.2024.11.010_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-017-0338-0","article-title":"Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC medical research methodology"},{"key":"10.1016\/j.jtct.2024.11.010_bib0016","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/cpt.2424","article-title":"Replication of Oncology Randomized Trial Results using Swedish Registry Real World-Data: A Feasibility Study","volume":"110","author":"Jemielita","year":"2021","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.jtct.2024.11.010_bib0017","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41571-019-0167-7","article-title":"Real-world data: towards achieving the achievable in cancer care","volume":"16","author":"Booth","year":"2019","journal-title":"Nature reviews Clinical oncology"},{"key":"10.1016\/j.jtct.2024.11.010_bib0018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41746-021-00452-1","article-title":"Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimer's disease","volume":"4","author":"Chen","year":"2021","journal-title":"NPJ digital medicine"},{"key":"10.1016\/j.jtct.2024.11.010_bib0019","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40801-022-00294-7","article-title":"Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer","volume":"9","author":"Holleman","year":"2022","journal-title":"Drugs-Real World Outcomes"},{"key":"10.1016\/j.jtct.2024.11.010_bib0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.annonc.2021.12.015","article-title":"External control arms in oncology: current use and future directions","volume":"33","author":"Mishra-Kalyani","year":"2022","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.jtct.2024.11.010_bib0021","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41467-022-30908-1","article-title":"Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer","volume":"13","author":"Popat","year":"2022","journal-title":"Nature communications"},{"key":"10.1016\/j.jtct.2024.11.010_bib0022","doi-asserted-by":"crossref","first-page":"W163","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"147","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2024.11.010_bib0023","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"Journal of clinical oncology"},{"key":"10.1016\/j.jtct.2024.11.010_bib0024","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.11.010_bib0025","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1200\/JCO.21.02614","article-title":"Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project","volume":"40","author":"D'Agostino","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.11.010_bib0026","first-page":"e528","article-title":"Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"5","author":"Dimopoulos","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jtct.2024.11.010_bib0027","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.6004\/jnccn.2023.0061","article-title":"Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Kumar","year":"2023","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"10.1016\/j.jtct.2024.11.010_bib0028","doi-asserted-by":"crossref","first-page":"169","DOI":"10.20517\/cdr.2022.138","article-title":"Anti-BCMA novel therapies for multiple myeloma","volume":"6","author":"Sammartano","year":"2023","journal-title":"Cancer Drug Resistance"},{"key":"10.1016\/j.jtct.2024.11.010_bib0029","first-page":"3225","article-title":"APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment","volume":"127","author":"Tai","year":"2016","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.jtct.2024.11.010_bib0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa2203478","article-title":"Teclistamab in relapsed or refractory multiple myeloma","volume":"387","author":"Moreau","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jtct.2024.11.010_bib0031","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(21)01338-6","article-title":"Teclistamab, a B-cell maturation antigen\u00d7 CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study","volume":"398","author":"Usmani","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.jtct.2024.11.010_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00962-7","article-title":"BCMA-targeted immunotherapy for multiple myeloma","volume":"13","author":"Yu","year":"2020","journal-title":"Journal of hematology & oncology"},{"key":"10.1016\/j.jtct.2024.11.010_bib0033","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s40265-023-01945-x","article-title":"Talquetamab: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jtct.2024.11.010_bib0034","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1182\/blood-2023-177669","volume":"142","author":"Dekhtiarenko","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.11.010_bib0035","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-World Evidence - What Is It and What Can It Tell Us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2024.11.010_bib0036","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity Analysis in Observational Research: Introducing the E-Value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2024.11.010_bib0037","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/1740774519853565","article-title":"University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (afternoon panel session)","volume":"16","author":"Little","year":"2019","journal-title":"Clin Trials"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724007796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724007796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:02:46Z","timestamp":1769914966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724007796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2666636724007796"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.11.010","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Bispecific T-Cell Engagers in Relapsed\/Refractory Multiple Myeloma: A Real-World Data-Based Case-Controlled Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}